Exscientia Statistics
Total Valuation
Lobe Sciences has a market cap or net worth of 6.33 million. The enterprise value is 8.25 million.
| Market Cap | 6.33M |
| Enterprise Value | 8.25M |
Important Dates
The last earnings date was Thursday, July 24, 2025.
| Earnings Date | Jul 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 201.73M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -10.98% |
| Shares Change (QoQ) | +3.43% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 122.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 2.57 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.13 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.87, with a Debt / Equity ratio of 0.73.
| Current Ratio | 2.87 |
| Quick Ratio | 2.86 |
| Debt / Equity | 0.73 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.88 |
Financial Efficiency
Return on equity (ROE) is -480.97% and return on invested capital (ROIC) is -53.29%.
| Return on Equity (ROE) | -480.97% |
| Return on Assets (ROA) | -37.20% |
| Return on Invested Capital (ROIC) | -53.29% |
| Return on Capital Employed (ROCE) | -56.87% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Lobe Sciences has paid 23,990 in taxes.
| Income Tax | 23,990 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +75.68% in the last 52 weeks. The beta is 2.02, so Lobe Sciences's price volatility has been higher than the market average.
| Beta (5Y) | 2.02 |
| 52-Week Price Change | +75.68% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 43.60 |
| Average Volume (20 Days) | 268,003 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -181,237 |
| Operating Income | -2.16M |
| Pretax Income | -3.95M |
| Net Income | -3.87M |
| EBITDA | -2.11M |
| EBIT | -2.16M |
| Earnings Per Share (EPS) | -0.03 |
Balance Sheet
The company has 5.79 million in cash and 1.80 million in debt, giving a net cash position of 4.00 million.
| Cash & Cash Equivalents | 5.79M |
| Total Debt | 1.80M |
| Net Cash | 4.00M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.46M |
| Book Value Per Share | -0.02 |
| Working Capital | 3.79M |
Cash Flow
| Operating Cash Flow | -750,792 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Lobe Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 10.98% |
| Shareholder Yield | n/a |
| Earnings Yield | -61.12% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 10, 2022. It was a reverse split with a ratio of 0.1666667.
| Last Split Date | Jun 10, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.1666667 |
Scores
Lobe Sciences has an Altman Z-Score of -7.34 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.34 |
| Piotroski F-Score | 3 |